Vascular endothelial growth factor inhibitors (pegaptanib, ranibizumab and bevacizumab) in age-related macular degeneration treatment

Pichon-Riviere A, Augustovski F, Colantonio L
Record ID 32009100147
Spanish
Authors' methods: Review
Details
Project Status: Completed
Year Published: 2007
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Intravitreal Injections
  • Wet Macular Degeneration
  • Vascular Endothelial Growth Factor A
  • Angiogenesis Inhibitors
  • Macular Degeneration
  • Bevacizumab
  • Ranibizumab
Contact
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.